Systematic review / meta-analysis / 2021
Postmenopausal osteoporosis was linked to altered levels of several oxidative stress markers, including higher OSI and lower total antioxidant status.
A systematic review and meta-analysis of 36 studies evaluated 16 oxidative stress-related biomarkers in postmenopausal osteoporosis (PO) versus controls. Pooled results showed significantly increased levels of oxidative stress index (OSI), malondialdehyde (MDA), advanced oxidation protein products (AOPP), and vitamin B12 in the PO group, along with decreased total antioxidant status (TAS), total antioxidant power (TAP), catalase (CAT), glutathione peroxidase (GPx), uric acid (UA), and folate. TOS, SOD, hydroperoxides, PON1, NO, and homocysteine showed no overall significant differences, though subgroup analyses showed elevated erythrocyte NO and serum homocysteine, alongside decreased serum SOD.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis
- Who was studied
- Postmenopausal women with osteoporosis and control groups across 36 studies
- What was measured
- Levels of 16 oxidative stress-related biomarkers
THE PAPER
Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis: a systematic review and meta-analysis.
Zhao F, Guo L, Wang X, Zhang Y. Arch Osteoporos, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.